Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2021

Published: January 2021

No. of Pages: 116

Price:

Single User License: US $ 2900 US $ 2175
Corporate User License: US $ 5800 US $ 4350

Report Description
Table of Contents

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
- Liposome
- Microcapsules/Nanocapsules
- Microspheres/Nanosptheres
- Implants

Segment by Application
- Cataract
- Glaucoma
- Corneal Transplantation
- Others

By Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

By Company
- pSivida
- Allergan
- Icon Bioscience
- Ocular Therapeutix
- Neurotech Pharmaceuticals
- Santen Pharmaceutical
- Aciont Inc.
- Envisia Therapeutics
- GrayBug
- Innocore Pharmaceuticals
- OHR Pharmaceuticals
- PolyActiva
- TheraKine

Table of Contents

1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Sustained Release Ocular Drug Delivery Systems
1.2 Sustained Release Ocular Drug Delivery Systems Segment by Type
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Liposome
1.2.3 Microcapsules/Nanocapsules
1.2.4 Microspheres/Nanosptheres
1.2.5 Implants
1.3 Sustained Release Ocular Drug Delivery Systems Segment by Application
1.3.1 Sustained Release Ocular Drug Delivery Systems Sales Comparison by Application: (2021-2027)
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Global Sustained Release Ocular Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Revenue 2016-2027
1.4.2 Global Sustained Release Ocular Drug Delivery Systems Sales 2016-2027
1.4.3 Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2016 Versus 2021 Versus 2027

2 Sustained Release Ocular Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sustained Release Ocular Drug Delivery Systems Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Sites, Area Served, Product Type
2.5 Sustained Release Ocular Drug Delivery Systems Market Competitive Situation and Trends
2.5.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sustained Release Ocular Drug Delivery Systems Players Market Share by Revenue
2.5.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.3.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Country
3.3.2 North America Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.4.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country
3.4.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Region
3.5.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region
3.5.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country
3.6.2 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country
3.7.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sustained Release Ocular Drug Delivery Systems Historic Market Analysis by Type
4.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2016-2021)
4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2016-2021)
4.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type (2016-2021)

5 Global Sustained Release Ocular Drug Delivery Systems Historic Market Analysis by Application
5.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2016-2021)
5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2016-2021)
5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application (2016-2021)

6 Key Companies Profiled
6.1 pSivida
6.1.1 pSivida Corporation Information
6.1.2 pSivida Description and Business Overview
6.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.1.4 pSivida Product Portfolio
6.1.5 pSivida Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Icon Bioscience
6.3.1 Icon Bioscience Corporation Information
6.3.2 Icon Bioscience Description and Business Overview
6.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Icon Bioscience Product Portfolio
6.3.5 Icon Bioscience Recent Developments/Updates
6.4 Ocular Therapeutix
6.4.1 Ocular Therapeutix Corporation Information
6.4.2 Ocular Therapeutix Description and Business Overview
6.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ocular Therapeutix Product Portfolio
6.4.5 Ocular Therapeutix Recent Developments/Updates
6.5 Neurotech Pharmaceuticals
6.5.1 Neurotech Pharmaceuticals Corporation Information
6.5.2 Neurotech Pharmaceuticals Description and Business Overview
6.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Neurotech Pharmaceuticals Product Portfolio
6.5.5 Neurotech Pharmaceuticals Recent Developments/Updates
6.6 Santen Pharmaceutical
6.6.1 Santen Pharmaceutical Corporation Information
6.6.2 Santen Pharmaceutical Description and Business Overview
6.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Santen Pharmaceutical Product Portfolio
6.6.5 Santen Pharmaceutical Recent Developments/Updates
6.7 Aciont Inc.
6.6.1 Aciont Inc. Corporation Information
6.6.2 Aciont Inc. Description and Business Overview
6.6.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aciont Inc. Product Portfolio
6.7.5 Aciont Inc. Recent Developments/Updates
6.8 Envisia Therapeutics
6.8.1 Envisia Therapeutics Corporation Information
6.8.2 Envisia Therapeutics Description and Business Overview
6.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Envisia Therapeutics Product Portfolio
6.8.5 Envisia Therapeutics Recent Developments/Updates
6.9 GrayBug
6.9.1 GrayBug Corporation Information
6.9.2 GrayBug Description and Business Overview
6.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.9.4 GrayBug Product Portfolio
6.9.5 GrayBug Recent Developments/Updates
6.10 Innocore Pharmaceuticals
6.10.1 Innocore Pharmaceuticals Corporation Information
6.10.2 Innocore Pharmaceuticals Description and Business Overview
6.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Innocore Pharmaceuticals Product Portfolio
6.10.5 Innocore Pharmaceuticals Recent Developments/Updates
6.11 OHR Pharmaceuticals
6.11.1 OHR Pharmaceuticals Corporation Information
6.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.11.4 OHR Pharmaceuticals Product Portfolio
6.11.5 OHR Pharmaceuticals Recent Developments/Updates
6.12 PolyActiva
6.12.1 PolyActiva Corporation Information
6.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.12.4 PolyActiva Product Portfolio
6.12.5 PolyActiva Recent Developments/Updates
6.13 TheraKine
6.13.1 TheraKine Corporation Information
6.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.13.4 TheraKine Product Portfolio
6.13.5 TheraKine Recent Developments/Updates

7 Sustained Release Ocular Drug Delivery Systems Manufacturing Cost Analysis
7.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
7.4 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sustained Release Ocular Drug Delivery Systems Distributors List
8.3 Sustained Release Ocular Drug Delivery Systems Customers

9 Sustained Release Ocular Drug Delivery Systems Market Dynamics
9.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
9.2 Sustained Release Ocular Drug Delivery Systems Growth Drivers
9.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
9.4 Sustained Release Ocular Drug Delivery Systems Market Restraints

10 Global Market Forecast
10.1 Sustained Release Ocular Drug Delivery Systems Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sustained Release Ocular Drug Delivery Systems by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Sustained Release Ocular Drug Delivery Systems by Type (2022-2027)
10.2 Sustained Release Ocular Drug Delivery Systems Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sustained Release Ocular Drug Delivery Systems by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Sustained Release Ocular Drug Delivery Systems by Application (2022-2027)
10.3 Sustained Release Ocular Drug Delivery Systems Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sustained Release Ocular Drug Delivery Systems by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Sustained Release Ocular Drug Delivery Systems by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Covered in This Study
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers (2016-2021)
Table 7. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Sustained Release Ocular Drug Delivery Systems Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Sites and Area Served
Table 11. Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 12. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 17. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 20. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 22. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 24. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Table 30. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 32. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 38. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2016-2021)
Table 39. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 40. Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) by Type (2016-2021)
Table 41. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2016-2021)
Table 42. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2016-2021)
Table 44. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 45. Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) by Application (2016-2021)
Table 46. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2016-2021)
Table 47. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2016-2021)
Table 48. pSivida Corporation Information
Table 49. pSivida Description and Business Overview
Table 50. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. pSivida Sustained Release Ocular Drug Delivery Systems Product
Table 52. pSivida Recent Developments/Updates
Table 53. Allergan Corporation Information
Table 54. Allergan Description and Business Overview
Table 55. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Allergan Sustained Release Ocular Drug Delivery Systems Product
Table 57. Allergan Recent Developments/Updates
Table 58. Icon Bioscience Corporation Information
Table 59. Icon Bioscience Description and Business Overview
Table 60. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product
Table 62. Icon Bioscience Recent Developments/Updates
Table 63. Ocular Therapeutix Corporation Information
Table 64. Ocular Therapeutix Description and Business Overview
Table 65. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product
Table 67. Ocular Therapeutix Recent Developments/Updates
Table 68. Neurotech Pharmaceuticals Corporation Information
Table 69. Neurotech Pharmaceuticals Description and Business Overview
Table 70. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 72. Neurotech Pharmaceuticals Recent Developments/Updates
Table 73. Santen Pharmaceutical Corporation Information
Table 74. Santen Pharmaceutical Description and Business Overview
Table 75. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product
Table 77. Santen Pharmaceutical Recent Developments/Updates
Table 78. Aciont Inc. Corporation Information
Table 79. Aciont Inc. Description and Business Overview
Table 80. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product
Table 82. Aciont Inc. Recent Developments/Updates
Table 83. Envisia Therapeutics Corporation Information
Table 84. Envisia Therapeutics Description and Business Overview
Table 85. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product
Table 87. Envisia Therapeutics Recent Developments/Updates
Table 88. GrayBug Corporation Information
Table 89. GrayBug Description and Business Overview
Table 90. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. GrayBug Sustained Release Ocular Drug Delivery Systems Product
Table 92. GrayBug Recent Developments/Updates
Table 93. Innocore Pharmaceuticals Corporation Information
Table 94. Innocore Pharmaceuticals Description and Business Overview
Table 95. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 97. Innocore Pharmaceuticals Recent Developments/Updates
Table 98. OHR Pharmaceuticals Corporation Information
Table 99. OHR Pharmaceuticals Description and Business Overview
Table 100. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 102. OHR Pharmaceuticals Recent Developments/Updates
Table 103. PolyActiva Corporation Information
Table 104. PolyActiva Description and Business Overview
Table 105. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. PolyActiva Sustained Release Ocular Drug Delivery Systems Product
Table 107. PolyActiva Recent Developments/Updates
Table 108. TheraKine Corporation Information
Table 109. TheraKine Description and Business Overview
Table 110. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. TheraKine Sustained Release Ocular Drug Delivery Systems Product
Table 112. TheraKine Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Sustained Release Ocular Drug Delivery Systems Distributors List
Table 116. Sustained Release Ocular Drug Delivery Systems Customers List
Table 117. Sustained Release Ocular Drug Delivery Systems Market Trends
Table 118. Sustained Release Ocular Drug Delivery Systems Growth Drivers
Table 119. Sustained Release Ocular Drug Delivery Systems Market Restraints
Table 120. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Type (2022-2027) & (K Pcs)
Table 121. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Application (2022-2027) & (K Pcs)
Table 125. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Region (2022-2027) & (K Pcs)
Table 129. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sustained Release Ocular Drug Delivery Systems
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2020 & 2027
Figure 3. Liposome Product Picture
Figure 4. Microcapsules/Nanocapsules Product Picture
Figure 5. Microspheres/Nanosptheres Product Picture
Figure 6. Implants Product Picture
Figure 7. Global Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2020 & 2027
Figure 8. Cataract
Figure 9. Glaucoma
Figure 10. Corneal Transplantation
Figure 11. Others
Figure 12. Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Sustained Release Ocular Drug Delivery Systems Market Size 2016-2027 (US$ Million)
Figure 14. Global Sustained Release Ocular Drug Delivery Systems Sales 2016-2027 (K Pcs)
Figure 15. Global Sustained Release Ocular Drug Delivery Systems Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers in 2020
Figure 17. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Sustained Release Ocular Drug Delivery Systems Players: Market Share by Revenue in 2020
Figure 19. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2016-2021)
Figure 21. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region in 2020
Figure 22. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Figure 23. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region in 2020
Figure 24. U.S. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2016-2021)
Figure 49. Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2016-2021)
Figure 50. Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application in 2020
Figure 51. Revenue Share of Sustained Release Ocular Drug Delivery Systems by Application (2016-2021)
Figure 52. Revenue Share of Sustained Release Ocular Drug Delivery Systems by Application in 2020
Figure 53. Manufacturing Cost Structure of Sustained Release Ocular Drug Delivery Systems
Figure 54. Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
Figure 55. Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group998770

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Sustained Release Ocular Drug Delivery Systems Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 Sustained Release Ocular Drug Delivery Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Sustained Release Ocular Drug Delivery Systems industry with a focus on the Chine...
Global Sustained Release Ocular Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2025 Snapshot The global Sustained Release Ocular Drug Delivery Systems market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The repor...
2020-2025 Global and Regional Sustained Release Ocular Drug Delivery Systems Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the Sustained Release Ocular Drug Delivery Systems market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 202...
Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2020 The global Sustained Release Ocular Drug Delivery Systems market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Sust...
Sustained Release Ocular Drug Delivery Systems Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026) Summary According to 99Strategy, the Global Sustained Release Ocular Drug Delivery Systems Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the glob...
Global Sustained Release Ocular Drug Delivery Systems Market Insights and Forecast to 2026 Sustained Release Ocular Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sustained Release Ocular Drug Delivery Systems market will be able to gain the upper hand as t...
Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2020 (Covid-19 Version) Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Liposome - Microcapsules/Nanoc...
2015-2025 Global Sustained Release Ocular Drug Delivery Systems Market Research by Type, End-Use and Region Summary The global Sustained Release Ocular Drug Delivery Systems market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter...
Global and United States Sustained Release Ocular Drug Delivery Systems Market Insights, Forecast to 2026 Sustained Release Ocular Drug Delivery Systems market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sustained Release Ocular Drug Delivery Systems market will be ab...
(COVID-19 Version) Global Sustained Release Ocular Drug Delivery Systems Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use Summary The report forecast global Sustained Release Ocular Drug Delivery Systems market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report of...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *